Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries

Peer Review reports

Original Submission
20 Mar 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
10 Apr 2022	Reviewed	Reviewer Report - Guenka Petrova
10 May 2022	Reviewed	Reviewer Report
16 Jun 2022	Author responded	Author comments - Olina Efthymiadou
Resubmission - Version 3
16 Jun 2022	Submitted	Manuscript version 3
21 Jun 2022	Reviewed	Reviewer Report - Guenka Petrova
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
28 Jul 2022	Editorially accepted
20 Aug 2022	Article published	10.1186/s12913-022-08437-w

Back to article page